...
首页> 外文期刊>The Journal of Allergy and Clinical Immunology >The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology
【24h】

The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology

机译:过敏性疾病中的微生物组:当前的理解和未来机会 - 2017年美国过敏院,哮喘和免疫学和欧洲过敏和临床免疫学院的实践文件

获取原文
获取原文并翻译 | 示例
           

摘要

PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and immunology. PRACTALL 2017 is focused on what has been established regarding the role of the microbiome in patients with asthma, atopic dermatitis, and food allergy. This is complemented by outlining important knowledge gaps regarding its role in allergic disease and delineating strategies necessary to fill these gaps. In addition, a review of progress in approaches used to manipulate the microbiome will be addressed, identifying what has and has not worked to serve as a baseline for future directions to intervene in allergic disease development, progression, or both.
机译:实践是美国过敏院,哮喘和免疫学和欧洲过敏院和临床免疫学院的联合倡议,以提供关于过敏和免疫学领域的尖端主题的共同循证建议。 Spectall 2017专注于已经建立了微生物组在哮喘,特应性皮炎和食物过敏患者中的作用。 这是通过概述其在过敏性疾病中作用和填补这些差距所需的策略作用的重要知识差距补充。 此外,将解决用于操纵微生物组的方法的进展情况,确定有什么并没有用作未来方向,以介入过敏性疾病发展,进展或两者的基线。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号